Correlation Between Shattuck Labs and Kymera Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Shattuck Labs and Kymera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shattuck Labs and Kymera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shattuck Labs and Kymera Therapeutics, you can compare the effects of market volatilities on Shattuck Labs and Kymera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shattuck Labs with a short position of Kymera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shattuck Labs and Kymera Therapeutics.

Diversification Opportunities for Shattuck Labs and Kymera Therapeutics

0.28
  Correlation Coefficient

Modest diversification

The 3 months correlation between Shattuck and Kymera is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Shattuck Labs and Kymera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kymera Therapeutics and Shattuck Labs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shattuck Labs are associated (or correlated) with Kymera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kymera Therapeutics has no effect on the direction of Shattuck Labs i.e., Shattuck Labs and Kymera Therapeutics go up and down completely randomly.

Pair Corralation between Shattuck Labs and Kymera Therapeutics

Given the investment horizon of 90 days Shattuck Labs is expected to under-perform the Kymera Therapeutics. In addition to that, Shattuck Labs is 1.81 times more volatile than Kymera Therapeutics. It trades about -0.19 of its total potential returns per unit of risk. Kymera Therapeutics is currently generating about -0.14 per unit of volatility. If you would invest  4,876  in Kymera Therapeutics on August 24, 2024 and sell it today you would lose (471.00) from holding Kymera Therapeutics or give up 9.66% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy95.65%
ValuesDaily Returns

Shattuck Labs  vs.  Kymera Therapeutics

 Performance 
       Timeline  
Shattuck Labs 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Shattuck Labs has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Kymera Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kymera Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's primary indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Shattuck Labs and Kymera Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Shattuck Labs and Kymera Therapeutics

The main advantage of trading using opposite Shattuck Labs and Kymera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shattuck Labs position performs unexpectedly, Kymera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kymera Therapeutics will offset losses from the drop in Kymera Therapeutics' long position.
The idea behind Shattuck Labs and Kymera Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Fundamental Analysis
View fundamental data based on most recent published financial statements
CEOs Directory
Screen CEOs from public companies around the world
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets